Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Clin Dev Immunol ; 2013: 410521, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23606869

RESUMO

Immunosuppressive drugs commonly used in the treatment of psoriatic arthritis make patients more susceptible to viral, bacterial, and fungal infections because of their mechanism of action. They not only increase the risk of new infections but also act altering the natural course of preexisting infections. While numerous data regarding the reactivation of tuberculosis infection are available in the literature, poor information about the risk of reactivation or exacerbation of hepatitis viruses B and C infections during treatment with biologics has been reported. Furthermore, reported series with biological therapy included short periods of followup, and therefore, they are not adequate to verify the risk of reactivation in the long-term treatment. Our study evaluated patients with a history of hepatitis B and psoriatic arthritis treated with adalimumab and monitored up to six years. During the observation period, treatment was effective and well tolerated in all patients, and liver function tests and viral load levels remained unchanged.


Assuntos
Anticorpos Monoclonais Humanizados/administração & dosagem , Artrite Psoriásica/tratamento farmacológico , Anticorpos Anti-Hepatite B/sangue , Anticorpos Anti-Hepatite C/sangue , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adalimumab , Adulto , Idoso , Anticorpos Monoclonais Humanizados/efeitos adversos , Artrite Psoriásica/imunologia , Feminino , Humanos , Imunossupressores/administração & dosagem , Imunossupressores/efeitos adversos , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo , Carga Viral , Ativação Viral
4.
J Eur Acad Dermatol Venereol ; 19(1): 107-11, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15649204

RESUMO

Melkersson-Rosenthal syndrome (MRS) is a complex neuromucocutaneous disorder characterized by localized orofacial oedema and cranial nerve dysfunction, frequently associated with minor signs, including furrowed tongue. Complete forms are rare whereas mono- and oligosymptomatic variants are more common. A 71-year-old man presented with a 2-year history of relapsing and progressively persistent oedema of the right eyelids and periorbital region. A fissured tongue and telangiectatic rosacea had been present since the age of 50 and 60 years, respectively. The patient was also affected by essential hypertension and diabetes mellitus. A skin biopsy showed a marked upper dermal oedema, and small epithelioid cell granulomas arranged in perivascular and perilymphatic location. Collections of small epithelioid cells were occasionally observed within lymphatic spaces. No acid-fast bacteria, fungi or foreign bodies were detected. Intralesional corticosteroids induced transient improvement, whereas minocycline, clofazimine and dapsone have been ineffective. MRS may present with unilateral eyelid and periorbital swelling. Differential diagnoses of such cases may include a variety of cutaneous, ophthalmic and systemic diseases.


Assuntos
Doenças Palpebrais/diagnóstico , Síndrome de Melkersson-Rosenthal/diagnóstico , Idoso , Complicações do Diabetes/diagnóstico , Diagnóstico Diferencial , Edema/complicações , Edema/diagnóstico , Doenças Palpebrais/complicações , Humanos , Hipertensão/complicações , Masculino , Síndrome de Melkersson-Rosenthal/complicações
5.
Int J Clin Pract ; 58(12): 1177-9, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15646420

RESUMO

Exaggerated reactions to insect bites are characteristic of patients with haemoproliferative disorders, particularly chronic lymphocytic leukaemia (CLL). Skin lesions usually appear after the diagnosis of leukaemia and seem unrelated to laboratory findings, disease course or therapy. Rarely, the eruption may precede the diagnosis of the haematologic malignancy. The patients usually do not recall of insect bites, and the diagnosis may require histological and laboratory investigations to exclude specific lesions or autoimmune bullous diseases. Lesions may run a chronic course and represent a therapeutic challenge. Here, we report an adult patient with CLL who developed itchy recurrent papulovesicular and bullous lesions. Differential diagnosis was made with cutaneous specific lesions of CLL, bullous pemphigoid and pemphigus vulgaris, but laboratory and histological investigations confirmed the diagnosis of an insect bite reaction. The patient was treated with oral H1 anti-histamines and topical corticosteroids under occlusion, with marked improvement after 10 days.


Assuntos
Mordeduras e Picadas de Insetos/diagnóstico , Leucemia Linfocítica Crônica de Células B/complicações , Pênfigo/diagnóstico , Corticosteroides/uso terapêutico , Idoso , Diagnóstico Diferencial , Seguimentos , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Humanos , Mordeduras e Picadas de Insetos/complicações , Mordeduras e Picadas de Insetos/tratamento farmacológico , Masculino , Pênfigo/complicações , Recidiva
6.
J Dermatolog Treat ; 14(3): 184-8, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14522631

RESUMO

Epidermodysplasia verruciformis (EV) is characterized by abnormal genetically-determined susceptibility to widespread and persistent infection of the skin with human papillomaviruses (HPV). The infection results in disseminated pityriasis versicolor-like lesions and flat warts. Skin malignant changes are very common and occur on sun-exposed areas. Several treatments have been used but without consistent benefit. Recently, retinoids and alpha-interferon, alone or in combination, have been reported to be of value in the therapy of EV lesions. We present the case of a 43-year-old white female affected by EV who developed multiple squamous cell carcinomas in the oral and genital mucosae during the previous four years. Both wart and cancer lesions harbored HPV24 along with the novel putative HPV type FA51. The patient was treated with a combination of acitretin (0.2 mg/kg per day) and peginterferon alfa-2b (1 microg/kg per week s.c.) for one year, with marked improvement of verrucous lesions and no recurrence of mucosal cancer. Thereafter, interferon was stopped whereas acitretin therapy was continued, but a new Bowen's disease developed in the perianal region, and the acitretin dose was increased at 0.5 mg/kg per day. At six-month follow-up, only a low number of flat warts persisted, and no clinical signs of cutaneous or mucosal carcinoma were evident.


Assuntos
Acitretina/uso terapêutico , Antivirais/uso terapêutico , Carcinoma de Células Escamosas/tratamento farmacológico , Epidermodisplasia Verruciforme/tratamento farmacológico , Interferon-alfa/uso terapêutico , Ceratolíticos/uso terapêutico , Papillomaviridae/isolamento & purificação , Neoplasias Cutâneas/tratamento farmacológico , Adulto , Carcinoma de Células Escamosas/virologia , Quimioterapia Combinada , Epidermodisplasia Verruciforme/patologia , Feminino , Humanos , Interferon alfa-2 , Proteínas Recombinantes , Neoplasias Cutâneas/virologia
7.
J Eur Acad Dermatol Venereol ; 17(3): 331-3, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12702079

RESUMO

Actinomycosis is a granulomatous suppurative bacterial disease caused by anaerobic actinomyces, which presents primarily with the cervico-facial, thoracic, abdominal or pelvic form. Cutaneous involvement is well documented and it is usually secondary to local extension or exceptionally to ematogenous spreading from visceral sites. Primary cutaneous actinomycosis is very rare and usually associated with external trauma and/or local ischemia. We report on the case of a primary cutaneous actinomycosis of the forehead in a 59-year-old man with diabetes mellitus who had had a preceding cranial trauma and several cutaneous reconstructive surgical procedures. The patient was treated successfully with combined antibiotic therapy.


Assuntos
Actinomicose/diagnóstico , Diabetes Mellitus , Dermatopatias Bacterianas/diagnóstico , Actinomyces/isolamento & purificação , Actinomicose/tratamento farmacológico , Actinomicose/patologia , Amoxicilina/administração & dosagem , Diagnóstico Diferencial , Quimioterapia Combinada/administração & dosagem , Testa , Humanos , Masculino , Pessoa de Meia-Idade , Minociclina/administração & dosagem , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...